Please login to the form below

Not currently logged in


This page shows the latest memantine news and features for those working in and with pharma, biotech and healthcare.

Roche and Evotec’s Alzheimer’s drug ineffective

Roche and Evotec’s Alzheimer’s drug ineffective

disease – the cholinesterase inhibitors donepezil, galantamine and rivastigmine or glutamate NMDA receptor antagonist memantine.

Latest news

More from news
Approximately 0 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....